Metformin was reported to demonstrate an ability to reject various solid tumors in normal, but not T-cell-deficient SCID mice and it increased the numbers of CD8+ tumor-infiltrating lymphocytes (TILs), with multiple cytokine production, i.e., IL-2, TNFα, and IFN-γ [35]. Here, CD8A is linked to neoplasm.